Contract award · 27 Jan 2026

Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo)

United Lincolnshire Teaching Hospitals NHS Trust awarded “Radiopharmaceuticals Treatment of Prostate…” to Bayer Public Limited Company for £106k.

No competitionMedical equipment & pharmaceuticalsEast Midlands

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
United Lincolnshire Teaching Hospitals NHS Trust · Body governed by public law
Value
£105,600
Procedure
Single tender action (below threshold)
Sector
Medical equipment & pharmaceuticals · Medical equipments, pharmaceuticals and personal care products (CPV 33000000)
Timeline
  1. Contract date27 Jan 2026
  2. Published11 Mar 2026Published 43 days after the contract date

Description

Provision of Xofigo, drug to treat Prostate Cancer

About the supplier

More from United Lincolnshire Teaching Hospitals NHS Trust

All contracts

More won by Bayer Public Limited Company

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview